Atypical teratoid/rhabdoid tumors (ATRT): Improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy

Journal of Clinical Oncology

Volumn 23, Issue 7, 2005, Pages 1491-1499

  Tekautz, Tanya M ^a   Fuller, Christine E ^a   Blaney, Susan ^a   Fouladi, Maryam ^a   Broniscer, Alberto ^a   Merchant, Thomas E ^a   Krasin, Matthew ^a   Dalton, James ^a   Hale, Gregory ^a   Kun, Larry E ^a   Wallace, Dana ^a   Gilbertson, Richard J ^a   Gajjar, Amar ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; OXALIPLATIN; PREDNISONE; PROCARBAZINE; TOPOTECAN; TRANSCRIPTION FACTOR SNF; VINCRISTINE; SMARCC1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADOLESCENT; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHABDOID TUMOR; TERATOMA; TUMOR BIOPSY; ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; INFANT; MORTALITY; NEOPLASM; PATHOLOGY; PRESCHOOL CHILD; SURVIVAL RATE;

CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; NEOPLASMS, GERM CELL AND EMBRYONAL; PROGNOSIS; RHABDOID TUMOR; SURVIVAL RATE; TERATOMA; TRANSCRIPTION FACTORS;

EID: 20144383987     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.187     Document Type: Review

References (31)

1. Kleihues P, Louis DN, Scheithauer BW, et al: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-225, 2002
2. Packer RJ, Beigel JA, Blaney S, et al: Atypical teratoid/rhabdoid tumor of the central nervous system: Report on workshop. J Pediatr Hematol Oncol 24:337-342, 2002
3. Ho DM-T, Hsu C-Y, Wong T-T, et al: Atypical teratoid/rhabdoid tumor of the central nervous system: A comparative study with primitive neuroectodermal tumor/medulloblastoma. Acta Neuropathol 99:482-488, 2000
4. Hilden JM, Meerbaum S, Burger P, et al: Central nervous system atypical teratoid/rhabdoid tumor: Results of therapy in children enrolled in a registry. J Clin Oncol 22:2877-2884, 2004
5. Lutterbach J, Liegibel J, Koch D, et al: Atypical teratoid/rhabdoid tumors in adult patients: Case report and review of the literature. J Neurooncol 52:49-56, 2001
6. Arrazola J, Pedrosa I, Méndez R, et al: Primary malignant rhabdoid tumour of the brain in an adult. Neuroradiology 42:363-367, 2000
7. Pimentel J, Silva R, Pimentel T: Primary malignant rhabdoid tumors of the central nervous system: Considerations about two cases of adulthood presentation. J Neurooncol 61:121-126, 2003
8. Berrak SG, Özek MM, Canpolat C, et al: Association between DNA content and tumor suppressor gene expression and aggressiveness of atypical teratoid/rhabdoid tumors. Childs Nerv Syst 18:485-491, 2002
9. Fuller CE, Pfeifer J, Humphrey P, et al: Chromosome 22q dosage in composite extrarenal rhabdoid tumors: Clonal evolution or a phenotypic mimic? Hum Pathol 32:1102-1108, 2001
10. Biegel JA, Allen CS, Kawasaki K, et al: Narrowing the critical region for a rhabdoid tumor iocus in 22q11. Genes Chromosomes Cancer 16:94-105, 1996
11. Zhang Z-K, Davies KP, Allen J, et al: Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5. Molec Cell Biol 22:5975-5988, 2002
12. Biegel JA, Fan LT, Zhang F, et al: Alterations of the hSNFS/INI1 gene in central nervous system atypical teratoid rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 8:3461-3467, 2002
13. Rousseau-Merck M-F, Versteege I, Legrand I, et al: hSNF5/INI1 Inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors. Cancer Res 59:3152-3156, 1999
14. Biegel JA, Fogelgren B, Wainwright LM, et al: Germline INI1 mutation in a patient with a central nervous system atypical teratoid/rhabdoid tumor. Genes Chromosom Cancer 20:31-37, 2002
15. Biegel JA, Zhou J-Y, Rorke LB, et al: Germ-line and acquired mutations of INI1 in atypical teratoid/rhabdoid tumors. Cancer Res 59:74-79, 1999
16. Dang T, Vassilyadi M, Michaud J, et al: Atypical teratoid/rhabdoid tumors. Childs Nerv Syst 19:244-248, 2003
17. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 54:457-81, 1958
18. Peto R, Pike MC, Armitage P, et al: I. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-39, 1977
19. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
20. Behring B, Brück W, Goebel HH, et al: Immunohistochemistry of primary central nervous system malignant rhabdoid tumors: Report of five cases and review of the literature. Acta Neuropathol 91:578-586, 1996
21. Merchant TE, Kun LE, Krasin MJ, Wallace D, et al: A multi-institutional prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose intensive chemotherapy for average-risk medulloblastoma. I J Radiat Oncol Biol Phys 57:194-195, 2000 (suppl, abstr)
22. Burger PC, Yu IT, Tihan T, et al: Atypical teratoid rhabdoid tumor of the central nervous system: A highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma. A Pediatric Oncology Group Study. Am J Surg Pathol 22:1083-1092, 1998
23. Fisher BJ, Siddiqui J, Macdonald D, et al: Malignant rhabdoid tumor of brain: An aggressive clinical entity. Can J Neurol Sci 23:257-263, 1996
24. Biegel JA, Fogelgren B, Zhou J-Y, et al: Mutations in the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system. Clin Cancer Res 6:2759-2763, 2000
25. Roberts CW, Orkin SH: The SWI/SNF complex-chromatin and cancer. Nat Rev Cancer 4:133-142, 2004
26. Rorke LB, Packer R, Biegel J: Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood. J Neurooncol 24:21-28, 1995
27. 1 arrest associated with induction of p16ink4a and activation of RB. Oncogene 21:5193-5203, 2002
28. Bruch LA, Hill DA, Cai DX, et al: A role for fluorescence in situ hybridization detection of chromosome 22q dosage in atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors. Hum Pathol 32:156-162, 2001
29. Bambakidis NC, Robinson S, Cohen M, et al: Atypical teratoid/rhabdoid tumor of the central nervous system: Clinical, radiographic and pathologic features. Pediatr Neurosurg 37:64-70, 2002
30. Hilden JM, Watterson J, Longee DC, et al: Central nervous system atypical teratoid/rhabdoid tumor: Response to intensive therapy and review of the literature. J Neurooncol 40:265-275, 1998
31. Reinhardt D, Behnke-Mursch J, Weiss E, et al: Rhabdoid tumors of the central nervous system. Childs Nerv Syst 16:228-234, 2000